Mitral regurgitation is the most frequent valve disease in the world affecting more than 2% of the general population. The current standard of care is open heart surgical repair of the valves but is there another option? CEO and Founder Toufic Azar of Meacor is developing an innovative minimally invasive approach that could transform treatment. Tune in to learn more about how Toufic got started, and how he is navigating taking a novel medical device to market!